HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Photorefractive keratectomy for pediatric myopic anisometropia.

AbstractPURPOSE:
To evaluate the visual results of excimer laser photorefractive keratectomy (PRK) to treat pediatric patients with amblyopic myopic anisometropia in whom conventional amblyopia treatments have failed.
SETTING:
Instituto Oftalmológico de Alicante, University of Alicante, Spain.
METHODS:
Six patients aged 5 to 7 years with amblyopic myopic anisometropia were treated by PRK in the more myopic eye using a VISX Twenty-Twenty excimer laser. Minimum preoperative refraction in the amblyopic eyes ranged from -4.00 to -13.00 diopters and best corrected visual acuity (BCVA), from 20/40 to 20/400. All cases completed a minimum of 2 years follow-up of antiamblyopic treatment.
RESULTS:
After PRK, preoperative BCVA was maintained without optical correction and complementary refraction resulted in increased BCVA in every case. One patient with high myopia developed severe haze. There were no other significant complications.
CONCLUSION:
Our results indicate that PRK may be an alternative for the correction of pediatric myopic anisometropia and an important aid in treating amblyopia. When other therapies have failed, using PRK in children of the ages in this study must be carefully evaluated; however, our results suggest a beneficial effect.
AuthorsJ L Alió, A Artola, P Claramonte, M J Ayala, E Chipont
JournalJournal of cataract and refractive surgery (J Cataract Refract Surg) Vol. 24 Issue 3 Pg. 327-30 (Mar 1998) ISSN: 0886-3350 [Print] United States
PMID9559467 (Publication Type: Case Reports, Journal Article)
Topics
  • Amblyopia (etiology, prevention & control)
  • Anisometropia (complications, physiopathology, surgery)
  • Child
  • Child, Preschool
  • Cornea (physiopathology, surgery)
  • Female
  • Follow-Up Studies
  • Humans
  • Lasers, Excimer
  • Male
  • Myopia (complications, physiopathology, surgery)
  • Photorefractive Keratectomy
  • Treatment Outcome
  • Visual Acuity (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: